These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38589352)

  • 1. Transglutaminase 3 regulates cutaneous squamous carcinoma differentiation and inhibits progression via PI3K-AKT signaling pathway-mediated Keratin 14 degradation.
    Zhou K; Wu C; Cheng W; Zhang B; Wei R; Cheng D; Li Y; Cao Y; Zhang W; Yao Z; Zhang X
    Cell Death Dis; 2024 Apr; 15(4):252. PubMed ID: 38589352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lncRNA EZR‑AS1 knockdown represses proliferation, migration and invasion of cSCC via the PI3K/AKT signaling pathway.
    Lu D; Sun L; Li Z; Mu Z
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RBM3 Inhibits the Cell Cycle of Cutaneous Squamous Cell Carcinoma through the PI3K/AKT Signaling Pathway.
    Huang Y; Sun W; Zhu D; Liu L; Feng J; Yi Q
    Curr Mol Pharmacol; 2024; 17():e18761429323760. PubMed ID: 39041256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGM3 functions as a tumor suppressor by repressing epithelial‑to‑mesenchymal transition and the PI3K/AKT signaling pathway in colorectal cancer.
    Feng Y; Ji D; Huang Y; Ji B; Zhang Y; Li J; Peng W; Zhang C; Zhang D; Sun Y; Xu Z
    Oncol Rep; 2020 Mar; 43(3):864-876. PubMed ID: 32020212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA LINC00520 prevents the progression of cutaneous squamous cell carcinoma through the inactivation of the PI3K/Akt signaling pathway by downregulating EGFR.
    Mei XL; Zhong S
    Chin Med J (Engl); 2019 Feb; 132(4):454-465. PubMed ID: 30707166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transglutaminase 3 suppresses proliferation and cisplatin resistance of cervical cancer cells by inactivation of the PI3K/AKT pathway.
    Chen R; Fang T; Liu N; Shi X; Wang J; Yu H
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2269-2280. PubMed ID: 37812238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of kynureninase restrains cutaneous squamous cell carcinoma proliferation and represses the PI3K/AKT pathway.
    Ci C; Wu C; Lyu D; Chang X; He C; Liu W; Chen L; Ding W
    Clin Exp Dermatol; 2020 Mar; 45(2):194-201. PubMed ID: 31419330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. circ_0001821 Contributes to the Development of Cutaneous Squamous Cell Carcinoma by Regulating MicroRNA-148a-3p/EGFR Axis and Activating Phosphatidylinositol 3-Kinase/Akt Pathway.
    Zhang Z; Deng X
    Mol Cell Biol; 2022 Mar; 42(3):e0008921. PubMed ID: 35191745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artesunate restrains the malignant progression of human cutaneous squamous cell carcinoma cells via the suppression of the PI3K/AKT pathway.
    Huang X; Zhang S; Wang W
    Tissue Cell; 2022 Jun; 76():101789. PubMed ID: 35338984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NPHS2-6 drives cervical squamous cell carcinoma (CSCC) progression via hsa-miR-1323/SMC1B axis to activate PI3K-Akt pathway.
    Li F; Wang Y; Wen M; Aizezi G; Yuan J; Zhou T; Shen G
    Clin Transl Oncol; 2024 Jan; 26(1):245-259. PubMed ID: 37322227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E2F Transcription Factor 1 Activates FKBP Prolyl Isomerase 4 to Promote Angiogenesis in Cervical Squamous Cell Carcinoma Via the PI3K/AKT Signaling Pathway.
    Huang J; Zhao Y
    Reprod Sci; 2023 Apr; 30(4):1229-1240. PubMed ID: 35849266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TUSC3 inhibits cell proliferation and invasion in cervical squamous cell carcinoma via suppression of the AKT signalling pathway.
    Sun F; Jie Q; Li Q; Wei Y; Li H; Yue X; Ma Y
    J Cell Mol Med; 2022 Mar; 26(5):1629-1642. PubMed ID: 35137520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth and Viability of Cutaneous Squamous Cell Carcinoma Cell Lines Display Different Sensitivities to Isoform-Specific Phosphoinositide 3-Kinase Inhibitors.
    Mannella V; Boehm K; Celik S; Ali T; Mirza AN; El Hasnaouy M; Kaffa A; Lyu Y; Kafaei Golahmadi D; Leigh IM; Bergamaschi D; Harwood CA; Maffucci T
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGM3 promotes epithelial-mesenchymal transition and hepatocellular carcinogenesis and predicts poor prognosis for patients after curative resection.
    Hu JW; Yang ZF; Li J; Hu B; Luo CB; Zhu K; Dai Z; Cai JB; Zhan H; Hu ZQ; Hu J; Cao Y; Qiu SJ; Zhou J; Fan J; Huang XW
    Dig Liver Dis; 2020 Jun; 52(6):668-676. PubMed ID: 31822388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Yes-associated protein (YAP) promotes invasion and migration of cutaneous squamous cell carcinoma cells by activating the PI3K/AKT pathway].
    Li Z; Yang F; Jin X; Wang X; Chen T; Quan C
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Mar; 40(3):244-251. PubMed ID: 38512035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tra2β silencing suppresses cell proliferation in laryngeal squamous cell carcinoma via inhibiting PI3K/AKT signaling.
    Ni HS; Hu SQ; Chen X; Liu YF; Ni TT; Cheng L
    Laryngoscope; 2019 Sep; 129(9):E318-E328. PubMed ID: 30597574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of DEAD-box 51 inhibits tumor growth of esophageal squamous cell carcinoma
    Hu DX; Sun QF; Xu L; Lu HD; Zhang F; Li ZM; Zhang MY
    World J Gastroenterol; 2022 Jan; 28(4):464-478. PubMed ID: 35125830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of T-cadherin inhibits the proliferation of oral squamous cell carcinoma through the PI3K/AKT/mTOR intracellular signalling pathway.
    Wang Q; Zhang X; Song X; Zhang L
    Arch Oral Biol; 2018 Dec; 96():74-79. PubMed ID: 30195142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FERMT1 knockdown inhibits oral squamous cell carcinoma cell epithelial-mesenchymal transition by inactivating the PI3K/AKT signaling pathway.
    Wang X; Chen Q
    BMC Oral Health; 2021 Nov; 21(1):598. PubMed ID: 34814915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
    Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
    Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.